#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Mike McGrath Email
Chief Scientific Officer . Neuvivo
How to contact Mike McGrath
Join and see Mike's contact info for free!Current Roles
Employees:
9Revenue:
$697.5kAbout
Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS. NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.Neuvivo Address
530 Lytton Avenull, null